Dextech Medical AB (XSAT:DEX)
9.98
+0.28 (2.89%)
At close: Sep 14, 2026
Dextech Medical AB Balance Sheet
Financials in millions SEK. Fiscal year is July - June.
Millions SEK. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 8.63 | 14.71 | 19.04 | 25.24 | 35.47 |
Cash & Short-Term Investments | 8.63 | 14.71 | 19.04 | 25.24 | 35.47 |
Cash Growth | -41.32% | -22.76% | -24.54% | -28.86% | 926.20% |
Accounts Receivable | 0.49 | - | - | - | - |
Other Receivables | - | 0.09 | 0.13 | 0.11 | 0.2 |
Receivables | 0.49 | 0.09 | 0.13 | 0.11 | 0.2 |
Other Current Assets | - | 0.38 | 0.5 | 0.47 | 0.35 |
Total Current Assets | 9.12 | 15.18 | 19.68 | 25.82 | 36.02 |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 |
Other Intangible Assets | 9.84 | 0.25 | 0.25 | 0.25 | 0.39 |
Long-Term Deferred Charges | - | 9.67 | 10.66 | 8.97 | 3.18 |
Total Assets | 18.95 | 25.1 | 30.59 | 35.03 | 39.59 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | - | 0.13 | 0.28 | 0.15 | 0.25 |
Accrued Expenses | - | 0.18 | 0.69 | 0.55 | 0.43 |
Other Current Liabilities | 0.65 | 0.02 | 0.01 | 0.02 | 0.03 |
Total Current Liabilities | 0.65 | 0.34 | 0.98 | 0.72 | 0.71 |
Total Liabilities | 0.65 | 0.34 | 0.98 | 0.72 | 0.71 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 18.3 | 0.83 | 0.83 | 0.83 | 0.83 |
Additional Paid-In Capital | - | 105.2 | 105.2 | 105.2 | 105.2 |
Retained Earnings | - | -81.26 | -76.42 | -71.71 | -67.15 |
Shareholders' Equity | 18.3 | 24.76 | 29.61 | 34.31 | 38.88 |
Total Liabilities & Equity | 18.95 | 25.1 | 30.59 | 35.03 | 39.59 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Cash (Debt) | 8.63 | 14.71 | 19.04 | 25.24 | 35.47 |
Net Cash Growth | -41.32% | -22.76% | -24.54% | -28.86% | 926.20% |
Net Cash Per Share | 0.47 | 0.79 | 1.01 | 1.37 | 2.09 |
Filing Date Shares Outstanding | 18.49 | 18.49 | 18.49 | 18.49 | 18.49 |
Total Common Shares Outstanding | 18.49 | 18.49 | 18.49 | 18.49 | 18.49 |
Working Capital | 8.47 | 14.85 | 18.7 | 25.1 | 35.31 |
Book Value Per Share | 0.99 | 1.34 | 1.60 | 1.86 | 2.10 |
Tangible Book Value | 8.47 | 24.51 | 29.36 | 34.07 | 38.49 |
Tangible Book Value Per Share | 0.46 | 1.33 | 1.59 | 1.84 | 2.08 |